Company: NUTR
Filing Date: 2025-08-15
Form Type: 424B3
Source: 0001641172-25-024295
Chunk: 172

Company: NUSATRIP Inc
Filing Date: 2025-08-15
Form: 424B3
Chunk 172
---
 X Super Voting Preferred Stock, $0.0001                                                                                           
 par value, 75,000 shares designated; 75,000 and 0 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively |     |           |           8 |   |     |          |          8 |   |
| Common stock, par value US$0.0001, 200,000,000                                                                                           
 shares authorized, 15,066,668 and 14,000,000 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively      |     |           |       1,507 |   |     |          |      1,400 |   |
| Additional paid-in capital                                                                                                               |     |           |   3,692,364 |   |     |          |  2,092,469 |   |
| Accumulated other comprehensive income                                                                                                   |     |           |     484,209 |   |     |          |    239,599 |   |
| Accumulated deficit                                                                                                                      |     |           |  (6,828,737 | ) |     |          | (6,292,518 | ) |
| Total equity attributable to Nusatrip Incorporated                                                                                       |     |           |  (2,650,657 | ) |     |          | (3,959,050 | ) |
| Non-controlling interest                                                                                                                 |     |           |  (1,869,017 | ) |     |          | (1,869,010 | ) |
| TOTAL                                                                                                                                    
 DEFICIT                                                                                                                                  |     |           |  (4,519,674 | ) |     |          | (5,828,060 | ) |
| TOTAL                                                                                                                                    
 LIABILITIES AND SHAREHOLDERS’ DEFICIT                                                                                                    |     | $         | (13,787,967 | ) |     | $        | 11,367,741 |   |

<div align='center'>See accompanying notes to carve-out combined and consolidated financial statements.</div>

| F-28 |

<div align='center'>NUSATRIP INCORPORATED

UNAUDITED INTERIM CONDENSED CARVE-OUT COMBINED AND CONSOLIDATED STATEMENTS OF OPERATIONS

AND COMPREHENSIVE INCOME (LOSS)

(Currency expressed in United States Dollars (“US$”))</div